IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q3 2026 Holdings

Filed 2026-11-02 | 3 holdings | $126.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$54.5M7,464,57243.0%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$53.1M2,182,33941.9%
Aura Biosciences Inc(AURA)COM05153U107$19.1M3,039,89215.1%